Recombinant Canis aureus Cytochrome c oxidase subunit 2 (MT-CO2)

Shipped with Ice Packs
In Stock

Description

Functional Role in Mitochondrial Respiration

MT-CO2 is a core subunit of cytochrome c oxidase (Complex IV), which catalyzes oxygen reduction to water during oxidative phosphorylation . Functional highlights:

  • Electron Transfer: Mediates electron shuttling from cytochrome c to the catalytic CuB-heme a3 site in subunit 1 via its CuA center .

  • Structural Role: Forms the functional core of Complex IV alongside MT-CO1 and MT-CO3 .

  • Pathological Relevance: Mutations in MT-CO2 are linked to mitochondrial disorders, including Leigh syndrome and Complex IV deficiency .

Research Applications

Recombinant MT-CO2 is widely used in biochemical and biomedical studies:

  • Enzyme Activity Assays: To study electron transport chain dysfunction in mitochondrial diseases .

  • Structural Studies: For resolving CuA center dynamics and proton channel mechanisms .

  • Antibody Production: Serves as an antigen for developing antibodies targeting cytochrome c oxidase .

Comparative Analysis of Recombinant MT-CO2 Variants

Data across species reveals conserved functional domains:

FeatureCanis aureus MT-CO2 Human MT-CO2
Amino Acid Length227 residues227 residues (Asp88–Leu227)
Expression RegionFull-length (1–227)Truncated (88–227)
Purity>90%>95%
Storage Stability-20°C/-80°C (lyophilized) -80°C (liquid)

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is specifically requested and agreed upon in advance. Additional fees apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
If a specific tag type is required, please inform us; we will prioritize development accordingly.
Synonyms
MT-CO2; COII; COX2; COXII; MTCO2; Cytochrome c oxidase subunit 2; Cytochrome c oxidase polypeptide II
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-227
Protein Length
full length protein
Species
Canis aureus (Golden jackal)
Target Names
Target Protein Sequence
MAYPFQLGLQDATSPIMEELLHFHDHALMIVFLISSLVLYIISLMLTTKLTHTSTMDAQE VETVWTILPAIILILIALPSLRILYMMDEINNPSLTVKTMGHQWYWSYEYTDYEDLNFDS YMIPTQELKPGELRLLEVDNRVVLPMEMTIRMLISSEDVLHSWAVPSLGLKTDAIPGRLN QTTLMAMRPGLYYGQCSEICGSNHSFMPIVLEMVPLSYFETWSALMV
Uniprot No.

Target Background

Function

Recombinant Canis aureus Cytochrome c oxidase subunit 2 (MT-CO2): A component of cytochrome c oxidase (Complex IV, CIV), the terminal enzyme in the mitochondrial electron transport chain responsible for oxidative phosphorylation. This chain comprises three multi-subunit complexes: succinate dehydrogenase (Complex II, CII), ubiquinol-cytochrome c oxidoreductase (Complex III, CIII), and cytochrome c oxidase (CIV). These complexes work in concert to transfer electrons from NADH and succinate to molecular oxygen, generating an electrochemical gradient across the inner mitochondrial membrane that drives ATP synthesis and transmembrane transport. Cytochrome c oxidase catalyzes the reduction of oxygen to water. Electrons from reduced cytochrome c in the intermembrane space (IMS) are transferred via the CuA center (subunit 2) and heme A (subunit 1) to the binuclear center (BNC) in subunit 1, composed of heme A3 and CuB. The BNC then reduces molecular oxygen to two water molecules using four electrons from cytochrome c in the IMS and four protons from the mitochondrial matrix.

Protein Families
Cytochrome c oxidase subunit 2 family
Subcellular Location
Mitochondrion inner membrane; Multi-pass membrane protein.

Q&A

What is the molecular function of MT-CO2 in Canis aureus mitochondria?

Cytochrome c oxidase subunit 2 (MT-CO2) is a critical component of the respiratory chain that catalyzes the reduction of oxygen to water. As observed in other species, MT-CO2 in Canis aureus functions as part of Complex IV in the electron transport chain, specifically transferring electrons from cytochrome c via its binuclear copper A center to the bimetallic center of the catalytic subunit 1 . This process is essential for cellular respiration and ATP production. The protein contains a conserved copper-binding domain that is crucial for its electron transfer function and ultimately contributes to the proton gradient across the inner mitochondrial membrane.

How does recombinant MT-CO2 expression differ from native protein expression?

Recombinant MT-CO2 expression systems aim to produce functional protein that mimics the native form, but several differences exist:

  • Post-translational modifications: Native MT-CO2 undergoes specific mitochondrial processing, including signal sequence processing by mitochondrial peptidases. Recombinant systems may not replicate these modifications precisely .

  • Protein folding dynamics: When expressed in heterologous systems, the protein may adopt slightly different conformational states due to differences in chaperone proteins and folding environments.

  • Metal ion incorporation: The proper incorporation of copper ions into the active site is critical for function but can be challenging to achieve in recombinant systems.

  • Membrane integration: As MT-CO2 is normally a multi-pass membrane protein in the mitochondrial inner membrane, recombinant expression systems must provide appropriate hydrophobic environments for proper folding and function .

What biosafety considerations apply when working with recombinant MT-CO2?

When working with recombinant MT-CO2 from Canis aureus, researchers should consider the following biosafety principles:

  • Risk assessment: Evaluate the potential hazards associated with the recombinant protein, including allergenic potential and biosafety level requirements .

  • Containment practices: Standard BSL-1 practices are typically sufficient for well-characterized recombinant proteins that are not known to cause disease in immunocompetent adults .

  • Laboratory procedures: Implement good microbiological practices including proper handling of biological materials, use of personal protective equipment, and appropriate waste disposal .

  • Institutional oversight: Ensure compliance with institutional biosafety committee guidelines for recombinant DNA and protein work .

  • Transportation considerations: Follow appropriate packaging and shipping regulations when transferring materials between facilities .

What expression systems are most effective for producing functional recombinant Canis aureus MT-CO2?

The selection of an appropriate expression system for Canis aureus MT-CO2 depends on several factors:

Expression SystemAdvantagesDisadvantagesRecommended Use Cases
E. coliHigh yield, rapid growth, cost-effectiveLimited post-translational modifications, inclusion body formationStructure studies, antibody production
Yeast (S. cerevisiae/P. pastoris)Better post-translational processing, eukaryotic systemLower yield than E. coli, longer expression timeFunctional studies requiring proper folding
Insect cellsGood for membrane proteins, eukaryotic processingMore complex, expensiveStructural studies, functional assays
Mammalian cellsNative-like processing and foldingLowest yield, highest cost, time-consumingInteraction studies, functional characterization

For recombinant MT-CO2, yeast expression systems may offer an optimal balance, as they provide mitochondrial-like processing while being more cost-effective than mammalian systems. Cyberlindnera species have demonstrated successful expression of cytochrome c oxidase components with proper copper incorporation .

How can researchers verify the functional integrity of recombinant MT-CO2?

Verification of functional integrity requires multiple complementary approaches:

  • Spectroscopic analysis: UV-visible spectroscopy to confirm characteristic absorbance patterns of properly folded cytochrome c oxidase components with incorporated metal centers.

  • Enzymatic activity assays: Measure electron transfer rates using reduced cytochrome c as substrate, monitoring the catalytic activity (4 ferrocytochrome c + O₂ + 4 H⁺ = 4 ferricytochrome c + 2 H₂O) .

  • Circular dichroism: Assess secondary structure elements to confirm proper folding.

  • Copper content analysis: Quantify copper incorporation using atomic absorption spectroscopy or inductively coupled plasma mass spectrometry.

  • Reconstitution experiments: Assess the ability of the recombinant protein to integrate into membrane fractions or liposomes and restore electron transport in depleted systems.

  • Thermal stability assays: Evaluate protein stability using differential scanning fluorimetry or similar techniques.

What are the optimal conditions for MT-CO2 protein purification while maintaining structural integrity?

Purification of membrane proteins like MT-CO2 requires careful consideration of detergent selection and buffer conditions:

  • Initial solubilization: Mild non-ionic detergents (e.g., n-dodecyl-β-D-maltoside or digitonin) at concentrations just above critical micelle concentration.

  • Buffer composition:

    • pH: Typically 7.2-7.8 to mimic physiological conditions

    • Salt concentration: 150-300 mM NaCl to maintain protein stability

    • Reducing agents: Low concentrations (1-2 mM) of DTT or TCEP to prevent oxidation of cysteine residues

    • Stabilizing agents: Glycerol (10-15%) to enhance protein stability

  • Purification strategy:

    • Initial capture: Immobilized metal affinity chromatography if using His-tagged constructs

    • Intermediate purification: Ion exchange chromatography

    • Final polishing: Size exclusion chromatography

  • Temperature considerations: Maintain samples at 4°C throughout purification to minimize degradation.

  • Metal ion supplementation: Consider adding low concentrations of copper ions (CuSO₄, 1-5 μM) to buffers to maintain the integrity of the copper-binding sites .

How do mutations in MT-CO2 copper-binding domains affect protein function and stability?

The copper-binding domains in MT-CO2 are critical for electron transfer function. Research indicates that mutations in these regions have multifaceted effects:

Mutations affecting copper coordination typically result in the most severe functional defects, as the binuclear copper center is essential for electron transfer from cytochrome c to the catalytic center . Experimental approaches to study these effects include site-directed mutagenesis followed by spectroscopic and kinetic analyses to characterize changes in redox potential and electron transfer capabilities.

What strategies can overcome challenges in heterologous expression of Canis aureus MT-CO2?

Several advanced strategies can address common challenges in heterologous expression:

  • Codon optimization: Adapt the Canis aureus MT-CO2 coding sequence to match the codon usage bias of the expression host, which can significantly improve translation efficiency.

  • Fusion partners:

    • Solubility enhancers: MBP (maltose-binding protein) or SUMO (small ubiquitin-like modifier) to improve folding

    • Affinity tags: His-tag or FLAG-tag for purification, positioned to minimize interference with function

    • Cleavable linkers: TEV or PreScission protease sites for tag removal

  • Chaperone co-expression: Co-express molecular chaperones specific to membrane protein folding (e.g., Hsp70 family proteins) to improve proper folding.

  • Expression conditions optimization:

    • Temperature reduction: Lower to 16-20°C during induction phase

    • Induction strategy: Use lower inducer concentrations for extended periods

    • Media supplementation: Add copper ions (1-10 μM CuSO₄) to media

  • Membrane-mimetic environments: Use specialized detergents or lipid nanodiscs during purification to maintain native-like environment for the membrane protein domains.

How can researchers differentiate between native and recombinant MT-CO2 in verification studies?

Distinguishing between native and recombinant MT-CO2 requires multiple analytical approaches:

  • Mass spectrometry analysis:

    • Intact protein mass analysis can detect differences in post-translational modifications

    • Peptide mapping can identify specific sequence differences or modifications

  • Epitope tagging:

    • Recombinant proteins can be engineered with specific tags (His, FLAG, etc.)

    • Use tag-specific antibodies for selective detection in western blots or immunoprecipitation

  • Protein sequence verification:

    • N-terminal sequencing to confirm proper processing of signal sequences

    • Internal peptide sequencing to verify sequence integrity

  • Post-translational modification profiling:

    • Phosphorylation site mapping

    • Glycosylation analysis

    • Metal content analysis to compare copper incorporation efficiency

  • Functional comparisons:

    • Enzymatic activity assays under standardized conditions

    • Thermal stability profiles using differential scanning fluorimetry

    • Spectroscopic properties using circular dichroism and UV-visible spectroscopy

How can recombinant MT-CO2 be used to study mitochondrial dysfunction in canine disease models?

Recombinant MT-CO2 serves as a valuable tool for investigating mitochondrial dysfunction in canine disease models through several approaches:

  • Structural studies:

    • X-ray crystallography or cryo-EM of recombinant protein to understand disease-associated structural changes

    • Comparative analysis between wild-type and mutant forms associated with pathological conditions

  • Functional assays:

    • In vitro electron transfer measurements using purified components

    • Reconstitution into liposomes or nanodiscs to study membrane-dependent activities

  • Interaction studies:

    • Identifying binding partners and regulatory proteins

    • Characterizing altered interactions in disease states

  • Antibody development:

    • Generation of specific antibodies for immunohistochemistry

    • Development of diagnostic tools for mitochondrial disorders

  • Drug discovery applications:

    • Screening compounds that might restore function in defective MT-CO2 variants

    • Structure-based drug design targeting MT-CO2 interaction surfaces

These approaches contribute to understanding canine mitochondrial disorders and potentially developing therapeutic interventions.

What controls should be included when conducting comparative studies between wild-type and mutant MT-CO2?

Robust experimental design requires comprehensive controls:

Control TypePurposeImplementation
Expression system controlsAccount for expression system variabilityExpress wild-type and mutant proteins simultaneously under identical conditions
Purification controlsEnsure comparable purityProcess samples through identical purification protocols, verify by SDS-PAGE and western blot
Tag position controlsAssess tag interferenceTest constructs with tags in different positions or tag-free proteins
Protein stability controlsDistinguish functional from stability effectsPerform thermal shift assays and limited proteolysis to assess structural integrity
Copper loading controlsEnsure proper cofactor incorporationQuantify metal content by atomic absorption spectroscopy, normalize enzymatic activity to copper content
Detergent/lipid environment controlsAccount for membrane environment differencesTest activity in multiple detergent types and reconstituted systems
Negative controlsEstablish baseline measurementsInclude catalytically inactive mutants (e.g., copper binding site mutations)

Additionally, time-course stability studies should be performed to ensure that observed differences are not due to differential degradation rates between wild-type and mutant proteins.

How does the sequence conservation of MT-CO2 across canid species impact research findings?

The evolutionary conservation of MT-CO2 across canid species has significant implications for research:

  • Sequence homology analysis:

    • Core functional domains (copper binding sites, cytochrome c interaction regions) show highest conservation

    • Species-specific variations often occur in less functionally critical regions

    • Conservation patterns can predict which mutations are likely to be functionally significant

  • Cross-species applicability:

    • High sequence similarity (~90-95% among canids) suggests findings may be translatable between closely related species

    • Species-specific variations require careful validation when extrapolating findings

  • Functional constraints:

    • Highly conserved residues are likely under strong selective pressure due to essential functions

    • Variations in less conserved regions may reflect adaptation to different metabolic demands

  • Evolutionary context:

    • Dating sequence divergence can correlate with speciation events

    • Molecular clock analyses using MT-CO2 can provide insights into canid evolution

Researchers should consider these conservation patterns when designing experiments and interpreting results, particularly when using recombinant proteins from one species as models for others.

What are common pitfalls in recombinant MT-CO2 expression and how can they be addressed?

Researchers frequently encounter several challenges when working with recombinant MT-CO2:

ChallengeManifestationSolution Approaches
Poor expressionLow yield, undetectable proteinOptimize codon usage, reduce expression temperature, try different promoters
Inclusion body formationInsoluble protein fractionCo-express chaperones, use solubility tags, optimize induction conditions
Improper copper incorporationReduced activity, altered spectral propertiesSupplement growth media with copper, optimize metal addition during purification
Proteolytic degradationMultiple bands on western blot, declining activityAdd protease inhibitors, reduce purification time, identify and mutate protease sites
Aggregation during purificationElution in void volume, precipitationScreen different detergents, include stabilizing agents, use gradient elution
Loss of activity over timeDeclining enzymatic functionStore with glycerol, avoid freeze-thaw cycles, optimize buffer conditions

Additionally, tracking protein throughout purification with activity assays rather than just protein concentration can help identify steps where functional protein is being lost.

How can researchers troubleshoot inconsistent electron transfer activity in recombinant MT-CO2 preparations?

Inconsistent electron transfer activity often stems from several factors that can be systematically addressed:

  • Copper content verification:

    • Quantify copper atoms per protein molecule using atomic absorption spectroscopy

    • Normalize activity to copper content rather than total protein

    • Re-metallate protein if copper content is sub-optimal

  • Redox state control:

    • Pre-treatment with mild reducing agents may be necessary to ensure proper redox state

    • Monitor redox state spectroscopically before activity measurements

  • Lipid environment optimization:

    • Test different detergent types and concentrations

    • Consider reconstitution into nanodiscs or liposomes with defined lipid composition

    • Cardiolipin supplementation can be particularly important for cytochrome c oxidase activity

  • Interaction partner quality:

    • Ensure cytochrome c used in assays is properly reduced

    • Verify cytochrome c quality by spectroscopic methods

    • Consider species compatibility between MT-CO2 and cytochrome c

  • Assay conditions refinement:

    • Optimize buffer composition, pH, and ionic strength

    • Control temperature precisely during measurements

    • Standardize protein concentration ranges to ensure linearity of assay

  • Storage optimization:

    • Determine optimal storage conditions (temperature, buffer composition)

    • Evaluate activity loss over time under different storage conditions

    • Consider flash-freezing aliquots in liquid nitrogen with cryoprotectants

What advanced analytical techniques can resolve discrepancies in MT-CO2 structural and functional data?

When faced with conflicting or inconsistent data, several advanced techniques can provide clarification:

  • High-resolution structural analysis:

    • Cryo-electron microscopy for membrane protein structures

    • Hydrogen-deuterium exchange mass spectrometry to probe conformational dynamics

    • Solid-state NMR for membrane-embedded structural information

  • Single-molecule techniques:

    • Single-molecule FRET to examine conformational states

    • Atomic force microscopy to probe topography and mechanical properties

    • Optical tweezers to study protein-protein interaction forces

  • Advanced spectroscopic methods:

    • Electron paramagnetic resonance (EPR) for copper center characterization

    • Resonance Raman spectroscopy for metal-ligand vibrations

    • Time-resolved spectroscopy to capture transient intermediates

  • Computational approaches:

    • Molecular dynamics simulations to predict conformational changes

    • Quantum mechanical calculations of electron transfer parameters

    • Integrative modeling combining multiple experimental datasets

  • In-membrane functional assessments:

    • Proteoliposome-based proton pumping assays

    • Membrane potential measurements in reconstituted systems

    • Patch clamp techniques for electrophysiological measurements

These advanced techniques can provide complementary data to resolve discrepancies and offer deeper insights into MT-CO2 structure-function relationships.

How might recombinant MT-CO2 contribute to comparative studies of mitochondrial evolution across canid species?

Recombinant MT-CO2 provides a powerful tool for investigating mitochondrial evolution:

  • Functional comparative studies:

    • Express MT-CO2 from multiple canid species to compare kinetic parameters

    • Investigate differences in thermal stability reflecting adaptation to environmental niches

    • Examine species-specific differences in proton pumping efficiency

  • Hybrid protein engineering:

    • Create chimeric proteins with domains from different canid species

    • Map functional differences to specific sequence variations

    • Reconstruct ancestral MT-CO2 sequences to study evolutionary trajectories

  • Co-evolution analysis:

    • Study interaction compatibility between MT-CO2 and cytochrome c from different species

    • Investigate co-evolution between nuclear-encoded and mitochondrial-encoded subunits

    • Examine selectivity of assembly factors across species

  • Adaptation signatures:

    • Correlate sequence variations with environmental adaptations (arctic vs. tropical canids)

    • Investigate metabolic efficiency differences related to hunting strategies

    • Examine positive selection signatures in specific MT-CO2 domains

These approaches can provide insights into how mitochondrial proteins evolve and adapt to different ecological niches while maintaining essential functions.

What potential applications exist for structural information derived from recombinant MT-CO2 studies?

Structural information derived from MT-CO2 studies has diverse applications:

  • Drug discovery:

    • Identify binding pockets for potential therapeutic compounds

    • Design inhibitors or activators of cytochrome c oxidase for specific applications

    • Develop compounds that could rescue function in mutant forms

  • Biomimetic catalyst design:

    • Engineer synthetic catalysts based on the copper center architecture

    • Develop improved oxygen reduction catalysts for fuel cells

    • Create biomimetic systems for controlled electron transfer

  • Protein engineering:

    • Design MT-CO2 variants with altered substrate specificity

    • Engineer proteins with enhanced stability for biotechnological applications

    • Create biosensors based on MT-CO2 electron transfer properties

  • Mitochondrial disease modeling:

    • Structure-based prediction of mutation impacts

    • Rational design of compensatory mutations

    • Development of structure-based screening assays for drug discovery

  • Comparative structural biology:

    • Understand species-specific adaptations at the structural level

    • Correlate structural differences with functional adaptations

    • Map evolutionary constraints on protein structure

These applications demonstrate how fundamental structural studies of MT-CO2 can lead to diverse practical applications in biotechnology and medicine.

How can emerging technologies in protein engineering enhance MT-CO2 research?

Cutting-edge protein engineering technologies offer new opportunities for MT-CO2 research:

  • Directed evolution approaches:

    • Develop specialized selection systems for improved MT-CO2 variants

    • Apply continuous evolution methods to optimize specific properties

    • Use compartmentalized self-replication to evolve variants with desired characteristics

  • Non-canonical amino acid incorporation:

    • Introduce photocrosslinking amino acids to capture transient interactions

    • Incorporate fluorescent amino acids for conformational studies

    • Use click-chemistry compatible amino acids for site-specific labeling

  • De novo design methods:

    • Apply computational design to engineer novel MT-CO2 variants

    • Create minimalist versions retaining core functionality

    • Design orthogonal electron transfer systems based on MT-CO2 architecture

  • CRISPR-based technologies:

    • Develop systems for precise genomic integration of engineered MT-CO2 variants

    • Create conditional expression systems for studying MT-CO2 function in vivo

    • Design base editing approaches for introducing specific mutations

  • Cell-free protein synthesis:

    • Optimize membrane protein expression in cell-free systems

    • Develop continuous exchange cell-free systems for enhanced yields

    • Create microfluidic platforms for high-throughput MT-CO2 variant screening

These emerging technologies expand the toolkit available to researchers, enabling more sophisticated experimental approaches and potentially accelerating discoveries in MT-CO2 biology.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.